News

First discovered in the Netherlands roughly 24 years ago, HMPV belongs to the same viral family as RSV.

One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it more difficult to be treated by traditional oral antidepressants.

The development of avian influenza vaccines is the main priority amid rising cases in the United States.

Health policy leaders say withdrawing from the WHO is a global health crisis in the making.

The president also promises to end the chronic disease epidemic and make two genders U.S. policy.

Datroway reduced disease progression by 37% when compared with chemotherapy.

Here’s what you missed this week on Managed Healthcare Executive.

A forecast of the year by Bill Kerr, M.D., MBA, CEO of Avalon Healthcare Solutions.

Jose Abrigo, Esq., HIV Project Director of the Lambda Legal Defense and Education Fund, explains the biggest HIV issues anticipated this year.

This ranking is based on the reviews of 12,372 consumers who evaluated their experiences with 16 major health insurance brands.

Michael Poku, M.D., chief clinical officer of Equality Health, shared his prediction for 2025.

But many existing models fall short of adhering to established best practices for economic evaluation, the review authors found. Another challenge: Existing models may not be well-suited for evaluating personalized treatments.

A prediction for 2025 from Laura Kohlhagen, M.D., MBA, chief medical officer, of Altera Digital Health.

Cancer mortality rates have decreased by 34% overall, but incidence rates for women of all ages continue to rise, according to a new report from the American Cancer Society.

More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the intestinal tract, when compared to placebo.

Berge will serve in this role through the end of 2026, marking another milestone in her successful career in healthcare.

Luke Twelves, M.D., vice president of Medical for Lindus Health, shared his prediction for the year.

Lyle Berkowitz, M.D., CEO of KeyCare, gives a prediction for 2025.

A prediction for 2025 by George Pappas, CEO of Intraprise Health.

The investigational drug, called PMD-026, is currently in phase 2 clinical trials for the treatment of breast cancer.

UnitedHealth Group reported a medical care ratio in 2024 of 85.5% compared with 83.2% in 2023.

A prediction for the year by Brandi Meyers, vice president of Revenue Operations at MDClone.

A South Korean study explored the link between lifestyle decisions beginning in infancy and persistent atopic dermatitis, citing exclusive breast milk diet and childhood obesity as potential factors.

Kim Perry, chief growth officer of Emtelligent, shares her prediction for 2025.

If approved, subcutaneous autoinjector Leqembi will be the only Alzheimer's medication that can be administered at home. The FDA has set a goal date of Aug. 31, 2025.

Study authors Susan D. Reed, MD, MPH, MS, and Erin Dwyer, MPH, both at the University of Washington School of Medicine, attribute some of these different challenges to underlying health disparities.

A prediction of 2025 by Doug Mirsky, Ph.D., vice president of healthcare delivery at Digital Medicine Society.

A prediction for this year by Shawn Gremminger, president and CEO of National Alliance of Healthcare Purchaser Coalitions.